PDS Biotechnology Statistics
Total Valuation
PDSB has a market cap or net worth of $108.20 million. The enterprise value is $65.68 million.
| Market Cap | 108.20M |
| Enterprise Value | 65.68M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PDSB has 36.68 million shares outstanding. The number of shares has increased by 14.42% in one year.
| Shares Outstanding | 36.68M |
| Shares Change (YoY) | +14.42% |
| Shares Change (QoQ) | +9.96% |
| Owned by Insiders (%) | 4.01% |
| Owned by Institutions (%) | 21.12% |
| Float | 35.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.91 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.65.
| Current Ratio | 4.56 |
| Quick Ratio | n/a |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.82 |
Financial Efficiency
Return on equity (ROE) is -146.00% and return on invested capital (ROIC) is -71.33%.
| Return on Equity (ROE) | -146.00% |
| Return on Assets (ROA) | -70.40% |
| Return on Capital (ROIC) | -71.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.76M |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.88% in the last 52 weeks. The beta is 1.82, so PDSB's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | -40.88% |
| 50-Day Moving Average | 3.19 |
| 200-Day Moving Average | 4.46 |
| Relative Strength Index (RSI) | 48.44 |
| Average Volume (20 Days) | 730,885 |
Short Selling Information
The latest short interest is 6.75 million, so 18.39% of the outstanding shares have been sold short.
| Short Interest | 6.75M |
| Short Previous Month | 6.71M |
| Short % of Shares Out | 18.39% |
| Short % of Float | 19.11% |
| Short Ratio (days to cover) | 13.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.72M |
| Pretax Income | -45.29M |
| Net Income | -43.89M |
| EBITDA | -43.60M |
| EBIT | -43.72M |
| Earnings Per Share (EPS) | -$1.37 |
Balance Sheet
The company has $66.63 million in cash and $24.11 million in debt, giving a net cash position of $42.53 million or $1.16 per share.
| Cash & Cash Equivalents | 66.63M |
| Total Debt | 24.11M |
| Net Cash | 42.53M |
| Net Cash Per Share | $1.16 |
| Equity (Book Value) | 37.18M |
| Book Value Per Share | 1.01 |
| Working Capital | 53.62M |
Cash Flow
| Operating Cash Flow | -30.39M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.39M |
| FCF Per Share | -$0.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PDSB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.42% |
| Shareholder Yield | -14.42% |
| Earnings Yield | -40.56% |
| FCF Yield | -28.08% |
Analyst Forecast
The average price target for PDSB is $16.67, which is 465.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.67 |
| Price Target Difference | 465.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -36.86% |
Stock Splits
The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |